ANPEP and B-cell non-Hodgkin lymphoma: In summary, we identified a conserved role of activated SUMOylation in restricting the MHC-I/APM pathway and showed that inhibition of SUMOylation restored the MHC-I/APM pathway in B cell lymphoma (BCL) cells.